Cross-country measures for monitoring epilepsy care (Q36744161)

16 August 2017

Cross-country measures for monitoring epilepsy care (English)

1 reference

16 August 2017

3

Ettore Beghi

1 reference

16 August 2017

Charles E Begley

1

1 reference

16 August 2017

Gus A Baker

2

1 reference

16 August 2017

James Butler

4

1 reference

16 August 2017

Daniel Chisholm

5

1 reference

16 August 2017

John T Langfitt

6

1 reference

16 August 2017

Pierre Levy

7

1 reference

16 August 2017

Christoph Pachlatko

8

1 reference

16 August 2017

Samuel Wiebe

9

1 reference

16 August 2017

Karen Lee Donaldson

10

1 reference

16 August 2017

ILAE Commission on Healthcare Policy

11

1 reference

16 August 2017

23 February 2007

1 reference

16 August 2017

1 reference

16 August 2017

48

1 reference

16 August 2017

990-1001

1 reference

16 August 2017

5

1 reference

The DALY, context and the determinants of the severity of disease: an exploratory comparison of paraplegia in Australia and Cameroon

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Can the value choices in DALYs influence global priority-setting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Early treatment cost in epilepsy and how it varies with seizure type and frequency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Health care reform in the new South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Active Coordination of the Longitudinal Observational Network in E

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Uptake and costs of care for epilepsy: findings from a U.K. regional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Global Campaign Against Epilepsy:the treatment gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Childhood secondary (symptomatic) epilepsy, seizure control, and intellectual handicap in a nontropical region of South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

The current status of neurocysticercosis in Eastern and Southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

NHS services for epilepsy from the patient's perspective: a survey of primary, secondary and tertiary care access throughout the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Epidemiology and aetiology of epilepsy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

The epidemiology of epilepsy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

National and regional prevalence of self-reported epilepsy in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Leptin in Relation to Hepatocellular Carcinoma in Patients with Liver Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

Clinically important change in quality of life in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

The Treatment Gap in Epilepsy: The Current Situation and Ways Forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00981.X

10.1111/J.1528-1167.2007.00981.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference